Last updated: July 07, 2026

Application No. 18/706,144

Untitled Application

Unknown

Filed

Priority

Oct 28, 2022 — provisional 63/381,349 +2 more

Examiner

RICCI, CRAIG D

Art Unit

Tech Center

Boehringer Ingelheim International GmbH

Assignee

Boehringer Ingelheim International GmbH

OA Round

1 (Non-Final)

This examiner grants 54% of cases after interview

— +52.8% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1146 resolved cases, 2023–2026

Examiner Intelligence

RICCI, CRAIG D View full profile →

Grants 54% of resolved cases

Career Allowance Rate

613 granted / 1146 resolved

-6.5% vs TC avg

Strong +53% interview lift

Without

With

+52.8%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

72 currently pending

Career history

1208

Total Applications

across all art units

Statute-Specific Performance

§101

0.1%

-39.9% vs TC avg

§103

49.7%

+9.7% vs TC avg

§102

11.5%

-28.5% vs TC avg

§112

8.1%

-31.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1146 resolved cases

Prosecution Timeline

Jul 02, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/762,443

Patent 12662452

SOLID STATE FORMS OF LUCERASTAT AND PROCESS FOR PREPARATION THEREOF

4y 3m to grant Granted Jun 23, 2026

18/613,333

Patent 12661321

SINGLE-INJECTION METHODS AND FORMULATIONS TO INDUCE AND CONTROL MULTIPLE OVARIAN FOLLICLES IN BOVINE, CAPRINE, OVINE, CAMELID AND OTHER FEMALE ANIMALS

2y 3m to grant Granted Jun 23, 2026

17/048,897

Patent 12655156

OXADIAZOLOPYRAZINES AND OXADIAZOLOPYRIDINES USEFUL AS MITOCHONDRIAL UNCOUPLERS

5y 8m to grant Granted Jun 16, 2026

17/844,934

Patent 12653769

ENHANCING PHOTOSTABILITY OF THIOPYRIDINONE COMPOUND WITHOUT THE USE OF UV FILTERS

3y 12m to grant Granted Jun 16, 2026

18/264,061

Patent 12649747

SALT FORM AND CRYSTAL FORM OF PYRAZOLE SUBSTITUTED IMIDAZO[1,2- A]QUINOXALINE DERIVATIVE

2y 10m to grant Granted Jun 09, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

54%

Grant Probability

99%

With Interview (+52.8%)

3y 3m

Median Time to Grant

Low

PTA Risk

Based on 1146 resolved cases by this examiner. Grant probability derived from career allowance rate.